NSN 6505-01-523-2380, 6505015232380
HALOPERIDOL TABLETS

Federal Supply Classification: FSC 6505 - Drugs and Biologicals
National Item Identification Number: NIIN 015232380
Codification Country: United States
Item Name Code: INC 30949
Criticality: (X) This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
Hazardous Material Indicator Code: (P) There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product.

Availability: Readily Available Qualified Suppliers: Currently qualifying suppliers

Manufacture or supply this part?
Join our growing community of certified suppliers.

Let Us Know

CALL ABOUT NSN 6505-01-523-2380

Our client representatives are standing by to help fulfill your request.

+1-321-773-5710

REQUEST QUOTE for 6505-01-523-2380

Have a list that needs to be quoted? Upload it here.

Upload a List

DLMS^® Summary

National Stock Number 6505-01-523-2380

National Stock Number (NSN) 6505-01-523-2380, or NIIN 015232380, (haloperidol tablets) was assigned August 25, 2004 in the Federal Logistics Information System (FLIS). This NIIN is Available for Manual Assignment. This NSN does not replace any other NSNs.

There are 3 manufacturer part numbers associated with this NSN. None of the associated part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by 2 suppliers. Today, 2 suppliers are listed as Active suppliers for this NSN. Of the active suppliers, 2 suppliers are deemed design controlled or valid supply parts.

This part number has not been procured by the US Government in over a year. There have been 4 contracts issued for this part number, with 4 awards given. There is minimal competition for this NSN. The US Government has awarded contracts to 3 different suppliers. The last contract numbers awarded were: SPE2DP21V0507, SPM2DP10M0425, SPM2DP10V0270, SPM2DP10V0104. The total value of the awarded contracts has been US$ 1,691.22.

There has been a small amount of demand for this national stock number. The demand for this NSN originated from less than 5 countries. Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on Dec 02, 2006, this NSN's acquisition method was noted as: Acquire directly from the actual manufacturer, whether or not the prime contractor is the actual manufacturer. This part is a commercial/non-developmental/off-the-shelf-item. Valid AMCs: 1, 2, 3, 4 and 5.

This NSN is assigned to Item Name Code (INC) 30949. []. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505015232380 does not contain precious metals.

This information was last updated on Jul 01, 2025.

Technical Characteristics

ACTIVE MEDICAMENT MEDICINAL STRENGTH: (AKJA) 5.000 KILOGRAMS PER CUBIC DECIMETER HALOPERIDOL CUBIC CENTIMETERS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: (AKJA) 5.000 MILLIGRAMS HALOPERIDOL ACTIVE INGREDIENT
ADMINISTRATION: (CSGS) ORAL
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: (AJUC) 281608
PART NAME ASSIGNED BY CONTROLLING AGENCY: (CXCY) HALOPERIODAL TABLETS 100S
MEDICAL DESIGNATION AND GRADE: (MDES) UNITED STATES PHARMACOPEIA
PRIMARY CONTAINER CONTENT QUANTITY: (CRLK) 100.000 TABLETS
PRIMARY CONTAINER TYPE: (CQCT) BOTTLE
SPECIAL FEATURES: (FEAT) USED TO TREAT NERVOUS, MENTAL AND EMOTIONAL CONDITIONS SUCH AS HALLUCINATIONS, DELUSIONS AND HOSTILITY AND TO CONTROL MUSCULAR TICS OF THE FACE, NECK, HANDS, AND SHOULDERS; KEEP TIGHTLY CLOSED; STORE AT ROOM TEMPERATURE AND AWAY FROM EXCESS HEAT AND MOISTURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: (CXCY) HALOPERIODAL TABLETS 100S
MEDICAL DESIGNATION: (MDES) UNITED STATES PHARMACOPEIA